HBOT for Healing & Inflammation

Where to start

OxyRevo

OxyRevo Quest36 1.5 to 2.0 ATA Hard Hyperbaric Chamber

Stainless Steel Construction2.0 ATA PressureOngoing US-Based Phone Support

$23,799

View model ›

SUMMIT TO SEA

Summit to Sea 40″ Dive Vertical Hyperbaric Chamber

1.3 ATA PressureMulti-Pressure ATA SettingsOngoing US-Based Phone Support

$13,995

View model ›

What Hyperbaric Therapy Actually Does to Inflamed Tissue

Hyperbaric oxygen therapy works on a straightforward physical principle: when you breathe concentrated oxygen inside a pressurized chamber, your blood plasma carries far more oxygen than it normally could. That surge of oxygen reaches tissues that are starved of it, including the swollen, poorly perfused tissue at the center of an inflammatory response.

Inflammation is not inherently a problem. It is the body's first-response system, sending immune cells, fluid, and signaling molecules to an injury site to begin repairs. The trouble comes when inflammation lingers well past its usefulness, becoming chronic and damaging the tissue it was meant to protect. This is the state that hyperbaric therapy inflammation research focuses on most heavily, and the results are consistent enough to take seriously.

At pressure, oxygen dissolves directly into plasma rather than riding only on red blood cells. This means it can penetrate areas where circulation is compromised, which are precisely the areas where inflammation tends to stall and where healing slows down. Researchers describe this as hyperoxygenation, and it triggers a cascade of downstream effects: changes in gene expression, shifts in inflammatory signaling, and stimulation of the repair processes that chronic inflammation tends to suppress.

The Inflammatory Cascade and Where HBOT Steps In

To understand why pressurized oxygen helps, it helps to know what the inflammatory cascade actually looks like at a cellular level. After injury or infection, immune cells called neutrophils and macrophages flood the site. They release pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1B), which amplify the response. Simultaneously, the body generates reactive oxygen species that kill pathogens but also damage surrounding healthy tissue when produced in excess.

HBOT appears to influence this process at multiple points. Studies have documented reductions in pro-inflammatory cytokine levels following repeated hyperbaric sessions. Research has also shown that HBOT can modulate neutrophil adhesion, the process by which immune cells stick to blood vessel walls and migrate into tissue. Reducing excessive neutrophil adhesion is significant because that migration is partly responsible for the collateral tissue damage that makes chronic inflammation so destructive.

At the same time, HBOT stimulates the production of vascular endothelial growth factor (VEGF) and promotes angiogenesis, the formation of new blood vessels. New vasculature brings fresh oxygen and nutrients to tissue that has been ischemic, breaking the cycle where poor blood supply prevents healing and poor healing perpetuates inflammation. This is one reason wound healing research has been so central to the clinical case for HBOT.

Chronic Inflammation Conditions: What the Evidence Shows

The research base for HBOT and inflammation spans a range of conditions, and not all of them are equally well-supported. The strongest evidence sits with conditions where tissue hypoxia and impaired healing are the core problem: diabetic foot ulcers, radiation-induced tissue damage, and non-healing surgical wounds. In these contexts, clinical use of HBOT is well-established and has been studied for decades.

Beyond wound care, a growing body of work has examined HBOT in conditions characterized by systemic or localized chronic inflammation. Fibromyalgia patients in controlled trials have shown reductions in pain and sensitivity following HBOT courses, with some researchers attributing this to changes in central sensitization and inflammatory signaling in the central nervous system. Inflammatory bowel conditions, inflammatory joint conditions, and post-viral fatigue syndromes have all been investigated, with results ranging from promising to preliminary.

Post-injury recovery is another area where hyperbaric therapy inflammation effects are frequently discussed. Athletes dealing with muscle tears, ligament injuries, or bone stress respond to HBOT partly because it reduces edema and accelerates the transition from the inflammatory phase of healing to the proliferative phase, where new collagen and tissue actually form. If you are interested in the specific athletic context, the evidence around muscle and connective tissue recovery is worth examining separately.

Pressure Levels: What They Mean for Inflammation Outcomes

Not all hyperbaric chambers operate at the same pressure, and this matters more than it might initially seem. The chambers available for home and wellness use generally fall into two categories: mild units operating at around 1.3 ATA and harder-shell units reaching 1.5 ATA, 1.6 ATA, or up to 2.0 ATA. The oxygen delivery and the physiological effects scale with pressure, though not always linearly.

Most of the foundational research on HBOT and inflammation used pressures in the 2.0 to 2.4 ATA range, typically administered in clinical or hospital settings. At those pressures, blood plasma oxygen saturation can reach roughly ten to fifteen times its normal level, which is a substantial driver of the cytokine-modulating and angiogenic effects described above. Mild-pressure chambers at 1.3 ATA still increase plasma oxygen well beyond normal breathing, but the magnitude is smaller.

That said, mild-pressure HBOT at 1.3 ATA has its own growing evidence base, particularly for wellness use and non-medical applications. Many of the Summit to Sea chambers operate at exactly 1.3 ATA (4.4 PSI), which is the FDA-cleared range for home use. The Summit to Sea 26" Shallow Dive, for instance, runs on a standard 120V outlet and is built around this pressure level, making it accessible for people who want regular, low-barrier sessions. For someone managing mild chronic inflammation rather than a specific clinical wound, consistent mild-pressure sessions may be more practical than infrequent high-pressure clinical sessions.

At the higher end, the OxyRevo Quest30 and Quest36 are adjustable between 1.5 and 2.0 ATA, which places them closer to the pressures used in clinical research. The Quest30 includes digital displays for pressure, oxygen purity, temperature, and humidity, along with an integrated 10-liter oxygen concentrator delivering 90 to 97% oxygen. That combination of higher pressure and concentrated oxygen significantly increases the dose of oxygen delivered to tissue compared to what a mild-pressure soft-shell unit achieves.

Soft-Shell vs. Hard-Shell Chambers for Inflammation Use

The shell type is more than a construction detail; it determines the maximum pressure the chamber can safely hold, which in turn shapes the kind of therapy it can deliver. Soft-shell chambers use flexible polyurethane or similar materials and are limited to mild pressures, usually 1.3 ATA. Hard-shell chambers, built from stainless steel or rigid acrylic composites, can reach 2.0 ATA and above.

For inflammation-specific goals, the choice between these two types depends on what you are trying to address and how frequently you plan to use the chamber. Soft-shell units are lighter, more portable, and less expensive. The Summit to Sea 40" Dive Vertical, for example, has a compact upright footprint at 85 inches tall and 40 inches in diameter, fits comfortably in a room that could not accommodate a full horizontal unit, and uses dual compressors for quiet operation. If your goal is regular, convenient sessions to support recovery from training or to address generalized low-level inflammation, a soft-shell unit at 1.3 ATA is a reasonable and practical tool.

Hard-shell chambers require more space, more infrastructure, and a higher initial investment, but they deliver a meaningfully higher oxygen dose. The OxyRevo Quest36 seats one adult or an adult with a child, includes dual control panels, integrated cooling and sterilization systems, and can be configured at pressures that match clinical protocols. For someone managing a specific health condition or seeking the closest approximation to clinical-grade HBOT at home, the harder-shell route makes more sense. A full breakdown of the tradeoffs is covered in the discussion of how these two construction types compare.

Comparing Home Hyperbaric Chambers for Inflammation Use

The table below covers the models most relevant to home or personal wellness use, drawing on the specifications published by each manufacturer. Where a figure was not published, it is noted as such.

Model	Max Pressure	Diameter	Shell Type	Price
Newtowne C4-27	1.3 ATA	27"	Soft	$4,095
Newtowne Shoe	1.3 ATA	Not published	Soft (seated)	$4,895
Newtowne Long Shoe	1.3 ATA	Not published	Soft (seated)	$5,495
OxyRevo Apex32	1.5 ATA	32"	Soft	$8,499
Newtowne Tent	1.3 ATA	54"	Soft (upright)	$8,195
OxyRevo Forward90	1.5 ATA	Not published	Soft (seated)	$9,199

The spread here is meaningful. If budget is the primary constraint and the goal is general wellness and inflammation management, the Newtowne C4-27 at $4,095 offers a practical entry point with 1.3 ATA and domestic manufacture. Moving up the range, the OxyRevo Forward90 adds a seated format, four large multilayer viewing windows, and an adjustable pressure range up to 1.5 ATA for someone who wants more pressure flexibility without committing to a full hard-shell unit. For the highest home pressure available in a soft-shell format, the Apex32 tops out at 1.5 ATA with optional upgrades including integrated red light therapy. Browsing the full hyperbaric chambers collection shows the complete range alongside current pricing.

How to Structure Sessions for Inflammation Recovery

Frequency and duration matter as much as pressure. The research on HBOT and inflammation generally uses protocols of 60 to 90 minutes per session, repeated across multiple weeks. Single sessions produce transient effects; the cumulative changes in gene expression, inflammatory signaling, and angiogenesis that research documents require repeated exposure to become durable.

For home use, the most practical starting point is five sessions per week for the first month, then reassessing based on response. This is more achievable than it sounds when the chamber is in your home and you do not need to drive to a clinic. Most people treat sessions like any other daily health habit, scheduling them in the morning or evening and using the time to read, listen to audio, or simply rest.

The gradual pressurization and depressurization that happens at the start and end of each session is also part of the experience, not just a mechanical necessity. Most chambers reach operating pressure within a few minutes; ears may need to equalize, similar to the sensation on an airplane descent. New users typically adapt within the first few sessions.

Combining HBOT with Other Recovery Modalities

HBOT works well alongside other recovery-focused interventions, and the combination can be more effective than either alone. Cold exposure reduces acute inflammation and vasoconstricts blood vessels, while HBOT promotes vasodilation and angiogenesis. Used in sequence, typically cold therapy first to manage acute swelling and HBOT after to drive tissue repair, the two modalities target different phases of the inflammatory process without working against each other.

Red light therapy is another natural companion. Photobiomodulation, the mechanism behind red light devices, influences cellular energy production through mitochondrial pathways and has its own anti-inflammatory evidence base. Some OxyRevo hard-shell chambers include integrated red light therapy as an optional upgrade, which allows both modalities to run simultaneously during a session. For those who want to build out a broader recovery setup, the red light therapy options pair well with hyperbaric use.

Nutrition, sleep, and movement all interact with how well HBOT's effects translate into actual tissue change. A chronically inflamed person who is also sleep-deprived and sedentary will likely see less benefit than someone who is addressing those variables alongside chamber use. HBOT amplifies the body's healing machinery; it does not replace the conditions that machinery needs to function.

Realistic Expectations: What HBOT Can and Cannot Do

Some of the broader claims made about HBOT and inflammation online are well ahead of the current evidence. Research generally finds that HBOT reduces markers of inflammation, accelerates healing in hypoxic tissue, and supports recovery from injury. It does not cure autoimmune conditions, and it is not a substitute for appropriate medical treatment of serious inflammatory diseases.

The people who tend to see the clearest benefit from home hyperbaric therapy fall into a few categories: those recovering from surgery or soft-tissue injuries, athletes managing the cumulative inflammatory load of heavy training, people with chronic low-level inflammation associated with metabolic or lifestyle factors, and those interested in the longevity applications that have drawn attention to HBOT's effects on cellular aging. Cognitive and neurological inflammation is another area of active investigation, with preliminary findings suggesting HBOT may reduce neuroinflammation; the research on oxygen therapy and brain function covers this in more detail.

Anyone managing a specific diagnosed condition should involve their physician in the decision to add HBOT. A doctor familiar with the therapy can advise on whether it is appropriate, at what pressure, and whether any contraindications apply. Conditions involving untreated pneumothorax, certain ear or sinus problems, and some medications that increase oxygen toxicity risk are the main areas of concern at clinical pressures. At mild home-use pressures, the risk profile is considerably lower, but that conversation is still worth having.

Choosing a Chamber Matched to Your Inflammation Goals

The right chamber depends on what you are managing, how often you intend to use it, and what your space and budget allow. For general wellness and mild inflammation management, a soft-shell unit at 1.3 ATA is a sensible and cost-effective starting point. Models like the Summit to Sea 26" Shallow Dive or the Newtowne C4-34 offer reliable performance in a format that fits most home environments and runs on standard household power.

If you are recovering from a significant injury, managing post-surgical healing, or want pressure levels that approach what clinical research uses, a unit with adjustable pressure between 1.5 and 2.0 ATA is worth the additional investment. The OxyRevo Quest30 at $21,249 and Quest36 at $23,799 both offer this range, along with the oxygen concentrators, safety systems, and comfort features that make sustained regular use realistic rather than burdensome.

Frequency of use is often the deciding factor that people underestimate. A premium chamber that fits your life and gets used daily will outperform a budget unit that sits unused because it is inconvenient. Size, format (horizontal versus vertical), ease of entry, and noise level from the compressor all affect whether sessions actually happen. The Summit to Sea 40" Dive Vertical's upright design is a good example of how format can expand who has practical access to regular sessions, particularly for users with mobility considerations or limited floor space.

More hyperbaric chambers worth a look

OxyRevo

OxyRevo Quest30 1.5 to 2.0 ATA Hard Hyperbaric Chamber

Stainless Steel ConstructionActive Cooling SystemOngoing US-Based Phone Support

$21,249

View model ›

SUMMIT TO SEA

Summit to Sea 26″ Shallow Dive Hyperbaric Chamber

Easy-Access Entry DesignQuality Inspected Before ShippingOngoing US-Based Phone Support

$7,995

View model ›

Frequently asked questions